Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nives Rombini"'
Autor:
Thomas Gruber, Mirela Kremenovic, Hassan Sadozai, Nives Rombini, Lukas Baeriswyl, Fabienne Maibach, Robert L. Modlin, Michel Gilliet, Diego von Werdt, Robert E. Hunger, S. Morteza Seyed Jafari, Giulia Parisi, Gabriel Abril-Rodriguez, Antoni Ribas, Mirjam Schenk
Publikováno v:
JCI Insight, Vol 5, Iss 18 (2020)
Myeloid cells orchestrate the antitumor immune response and influence the efficacy of immune checkpoint blockade (ICB) therapies. We and others have previously shown that IL-32 mediates DC differentiation and macrophage activation. Here, we demonstra
Externí odkaz:
https://doaj.org/article/73102a11a99b4a02ba1d66cddf9d8fe9
Autor:
Alfred A. Chan, Nives Rombini, Mirela Kremenovic, Delphine J. Lee, Thomas Gruber, Mirjam Schenk, Lukas Bäriswyl
Publikováno v:
Kremenovic, Mirela; Rombini, Nives; Chan, Alfred A.; Gruber, Thomas; Bäriswyl, Lukas; Lee, Delphine J.; Schenk, Mirjam (2020). Characterization of a Myeloid Activation Signature that Correlates with Survival in Melanoma Patients. Cancers, 12(6), p. 1431. MDPI AG 10.3390/cancers12061431
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1431, p 1431 (2020)
Cancers
Volume 12
Issue 6
Cancers, Vol 12, Iss 1431, p 1431 (2020)
Understanding the cellular interactions within the tumor microenvironment (TME) of melanoma paved the way for novel therapeutic modalities, such as T cell-targeted immune checkpoint inhibitors (ICI). However, only a limited fraction of patients benef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9fa5a721d629c7ab5faf58430a186a8
https://doi.org/10.3390/cancers12061431
https://doi.org/10.3390/cancers12061431